The teams of Prof. Yimin Cui and Prof. Zhenming Liu have discovered a potential new treatment for castration-resistant prostate cancer that targets integrin receptors
School of Pharmaceutical Sciences, Peking University Health Science Center
School of Pharmaceutical Sciences, Peking University Health Science Center
School of Pharmaceutical Sciences, Peking University Health Science Center. The teams of Prof. Yimin Cui and Prof. Zhenming Liu have discovered a potential new treatment for castration-resistant prostate cancer that targets integrin receptors[J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(2): 158-161.